Detailed Information
Cited 4 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Subcutaneous amivantamab (ami) in patients (pts) with advanced solid malignancies: The PALOMA study-Updated safety and identification of the recommended phase 2 dose
- Authors
- Minchom, AR[Minchom, Anna Rachel]; Krebs, MG[Krebs, Matthew G.]; Cho, BC[Cho, Byoung Chul]; Lee, SH[Lee, Se-Hoon]; Leighl, NB[Leighl, Natasha B.]; O'Neil, B[O'Neil, Bert]; Sabari, JK[Sabari, Joshua K.]; Kudgus-Lokken, R[Kudgus-Lokken, Rachel]; Alhadab, A[Alhadab, Ali]; Haddish-Berhane, N[Haddish-Berhane, Nahor]; Zemlickis, D[Zemlickis, Donna]; Mitselos, A[Mitselos, Anna]; Berkay, E[Berkay, Eileen]; Bauml, JM[Bauml, Joshua Michael]; Knoblauch, RE[Knoblauch, Roland E.]; Hellemans, P[Hellemans, Peter]; Johnson, ML[Johnson, Melissa Lynne]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.